Vor Biopharma Inc. (VOR) Revenue History
Annual and quarterly revenue from 2018 to present
VOR Revenue Over Time (2018–2025)
VOR Revenue Growth History
- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $0 | — |
| Q4 2025 | $0 | — |
| Q3 2025 | $0 | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
VOR Revenue Analysis (2018–2025)
Current Revenue & Growth
As of June 12, 2026, Vor Biopharma Inc. (VOR) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue
Historical Growth Trajectory
VOR's historical revenue data shows various trends over time.
Peer Comparison
Compared to Healthcare sector peers — including BEAM (+108.0% YoY), CRSP (-88.9% YoY), and EDIT (+8.0% YoY). Compare VOR vs BEAM →
VOR Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
 VORCurrent | $0 | - | - | - | |
 BEAM | $140M | +108.0% | +466.3% | -274.6% | |
 CRSP | $4M | -88.9% | +37.3% | -16191.4% | |
 EDIT | $41M | +8.0% | -14.9% | -245.2% | |
 NTLA | $68M | +45.0% | +3.1% | -651.7% | |
 FATE | $7M | -52.6% | -26.7% | -2222.4% |
VOR Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-371,642,000 | - |
| 2024 | $0 | - | $0 | - | $-121,185,000 | - |
| 2023 | $0 | - | $-3,492,000 | - | $-126,036,000 | - |
| 2022 | $0 | - | $-8,960,000 | - | $-93,418,000 | - |
| 2021 | $0 | - | $0 | - | $-69,018,000 | - |
| 2020 | $0 | - | $0 | - | $-43,366,000 | - |
| 2019 | $0 | - | $-91,000 | - | $-10,417,000 | - |
| 2018 | $0 | - | $-20,000 | - | $-2,860,000 | - |
What if you invested $1,000 in VOR back in 2018?
Total return with dividends reinvested · 8+ years of data
Calculate ReturnsHow much would $100/month in VOR be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs VOR Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationVOR vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowVOR — Frequently Asked Questions
Quick answers to the most common questions about buying VOR stock.
Is VOR's revenue growth accelerating or slowing?
VOR TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is VOR's revenue history from 2018 to 2026?
Vor Biopharma Inc. (VOR) revenue history spans 2018 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is VOR's long-term revenue growth rate (CAGR)?
Vor Biopharma Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for VOR.
Why does VOR's quarterly revenue fluctuate?
VOR quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Vor Biopharma Inc.'s revenue data from 2018 to 2026 shows full historical quarterly detail on this page.
How is VOR's revenue distributed by segment?
VOR reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does VOR's revenue compare to industry peers?
Vor Biopharma Inc. (VOR) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.